Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma

…, YH Ko, SJ Kim, R Suzuki, WS Kim - Blood, The Journal …, 2020 - ashpublications.org
Because non–anthracycline-based chemotherapy with l-asparaginase has improved survival
outcomes in patients with extranodal natural killer/T-cell lymphoma (ENKTL), the incidence …

[HTML][HTML] Circulating tumor cells enumerated by a centrifugal microfluidic device as a predictive marker for monitoring ovarian cancer treatment: A pilot study

H Kim, M Lim, JY Kim, SJ Shin, YK Cho, CH Cho - Diagnostics, 2020 - mdpi.com
We investigated the size-based isolation and enumeration of circulating tumor cells (CTCs)
using a centrifugal microfluidic device equipped with a fluid-assisted separation technology (…

[HTML][HTML] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

H Kim, M Kwon, B Kim, HA Jung, JM Sun, SH Lee… - BMC cancer, 2020 - Springer
Background Anti-PD1 inhibitors have been approved for the treatment of recurrent or metastatic
head and neck cancer (HNC), as a result of Global Phase III trials. However, the clinical …

[HTML][HTML] Synergistic effects of combination therapy with AKT and mTOR inhibitors on bladder cancer cells

H Kim, SJ Lee, IK Lee, SC Min, HH Sung… - International Journal of …, 2020 - mdpi.com
Despite comprehensive genomic analyses, no targeted therapies are approved for bladder
cancer. Here, we investigate whether a single and combination therapy with targeted agents …

Clinical implications of BRCA mutations in advanced biliary tract cancer

H Kim, JY Kim, KU Park - Oncology, 2023 - karger.com
… Acquisition of data: Hyera Kim, Jin Young Kim, and Keon Uk Park. Analysis and interpretation
of data: Hyera Kim. Drafting the manuscript: Hyera Kim. Critical revision of the manuscript …

[HTML][HTML] The prognostic factors influencing overall survival in uterine cervical cancer with brain metastasis

H Kim, KK Lee, MH Heo, JY Kim - The Korean Journal of Internal …, 2019 - ncbi.nlm.nih.gov
Methods A total of 19 BM patients of uterine cervical cancer were analyzed retrospectively
from January 1995 to December 2016. Results The median and mean OS of all patients was …

Programmed death ligand 1 expression as a prognostic marker in patients with advanced biliary tract cancer

H Kim, J Kim, S Byeon, KT Jang, JY Hong, J Lee… - Oncology, 2021 - karger.com
Background: Biliary tract cancer (BTC) is associated with poor prognosis because of its
aggressive and heterogeneous nature. Programmed death ligand 1 (PD-L1) has been …

[HTML][HTML] Predictors of relapse in patients with organizing pneumonia

…, H Kim, SS Yoo, J Lee, SY Lee, CH Kim… - Tuberculosis and …, 2015 - ncbi.nlm.nih.gov
Background Although organizing pneumonia (OP) responds well to corticosteroid therapy,
relapse is common during dose reduction or follow-up. Predictors of relapse in OP patients …

Dual biomarker combining DNA damage repair gene mutations and PD-L1 expression for immune checkpoint inhibitors in non-small cell lung cancer

H Kim, DH Lim, YS Kwon, MA Kim… - Anticancer Research, 2023 - ar.iiarjournals.org
… Acquisition of data: Hyera Kim, Dong Hyun Lim, Yong Shik Kwon, Mi Ae Kim, Keon Uk Park.
Analysis and interpretation of data: Hyera Kim. Drafting the manuscript: Hyera Kim, Dong …

[HTML][HTML] Clinical relevance of bronchial anthracofibrosis in patients with chronic obstructive pulmonary disease exacerbation

…, MJ Kim, YD Lee, M Kim, J Lee, CH Kim - Tuberculosis and …, 2014 - ncbi.nlm.nih.gov
Background Bronchial anthracofibrosis (BAF), which is associated with exposure to biomass
smoke in inefficiently ventilated indoor areas, can take the form of obstructive lung disease. …